Skip to main content
. 2022 May 25;23(11):5926. doi: 10.3390/ijms23115926

Figure 2.

Figure 2

Therapeutic potential of SSAT as a biomarker and target of polyamine analogs. (A) Conversion of amantadine to N-acetylamantadine by SSAT, followed by urinary excretion. (B) Common targets of SSAT; DENSpm resembles the structure of other SSAT substrates and resulted in superinduction of SSAT.